Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer

Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer

10.1102/1470-7330.2012.0021

Saved in:

Bibliographic Details
Main Authors:	Huellner, M.W., Hennedige, T.P., Winterhalder, R., Zander, T., Venkatesh, S.K., Yong, W.P., Soo, R.A., Seifert, B., Treumann, T.C., Strobel, K., Veit-Haibach, P.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Subjects:	Colorectal cancer CT measurement Prognosis Therapy response Tumor response
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/115247
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Performance of existing prognostic factors for colorectal cancer prognosis - a critical view
by: Sarkar, M., et al.
Published: (2013)

Proteomic analysis of colorectal cancer metastasis: Stathmin-1 revealed as a player in cancer cell migration and prognostic marker
by: Tan, H.T., et al.
Published: (2014)

Performance of existing prognostic factors for colorectal cancer prognosis - a critical view
by: Sarkar M.,, et al.
Published: (2001)

Current and emerging surveillance strategies to expand the window of opportunity for curative treatment after surgery in colorectal cancer
by: Lin Koo, S., et al.
Published: (2014)

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
by: Soong, R., et al.
Published: (2012)

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
by: Soong, R., et al.
Published: (2011)

Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy
by: Ma, X., et al.
Published: (2011)

Clinical significance of cancer stem cell markers and other related proteins in colorectal carcinomas - Biological and methodological considerations
by: ONG CHEE WEE
Published: (2011)

Accuracy of preoperative CT for local staging in colorectal carcinomas
by: Hennedige, T., et al.
Published: (2016)

Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer
by: Mochizuki, K, et al.
Published: (2023)

CD133 expression predicts for non-response to chemotherapy in colorectal cancer
by: Ong, C.W., et al.
Published: (2012)

EVALUATION OF NEW APPROACHES AND DISCOVERY OF MOLECULAR MARKERS RELATED TO THE NON-INVASIVE FECAL-BASED DETECTION OF COLORECTAL CANCER AND CLINICAL PREDICTION OF TREATMENT RESPONSE
by: PHUA LEE CHENG
Published: (2014)

Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring
by: Hennedige, T., et al.
Published: (2016)

Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
by: Farid, M., et al.
Published: (2016)

Metastasis-associated protein S100A4 - A potential prognostic marker for colorectal cancer
by: Hemandas, A.K., et al.
Published: (2012)

IMPACT ON THE QUALITY OF LIFE OF PATIENTS RECEIVING CHEMOTHERAPY FOR METASTATIC COLORECTAL CANCER: A SYSTEMATIC REVIEW
by: EDDIE HEE SHAO LUN
Published: (2021)

CT of blunt pancreatic trauma-A pictorial essay
by: Venkatesh, S.K., et al.
Published: (2011)

CT of blunt pancreatic trauma-A pictorial essay
by: Venkatesh, S.K., et al.
Published: (2011)

Editors' comments: Is corporate social responsibility research undertheorized?
by: WANG, Heli, et al.
Published: (2020)

MicroRNA Expression of Primary and Metastatic Colorectal and Breast Carcinoma
by: Thaniya Sricharunrat, et al.
Published: (2022)

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles
by: Bresalier, Robert S., et al.
Published: (2024)

K-ras mutation in colorectal carcinoma from Singapore
by: Phang, T.-W., et al.
Published: (2014)

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
by: Soong, R., et al.
Published: (2012)

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
by: Soong, R., et al.
Published: (2011)

THE ROLE OF ARTEMIN IN COLORECTAL CANCER PROGRESSION
by: ZHUANG QIUSHI
Published: (2015)

The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers
by: Subramaniam, M.M., et al.
Published: (2014)

Body mass index and risk of colorectal cancer in Chinese Singaporeans: The Singapore Chinese Health Study
by: Odegaard, A.O., et al.
Published: (2014)

Results of a colorectal enhanced recovery after surgery (ERAS) programme and a qualitative analysis of healthcare workers’ perspectives
by: Seow-En, Isaac, et al.
Published: (2022)

Germline genetic testing to predict drug response and toxicity in oncology- Reality or fiction?
by: Soh, T.I., et al.
Published: (2014)

IDENTIFICATION OF METASTASIS-ASSOCIATED BIOMARKER GENES IN TUMOR PROGRESSION AND LIVER METASTASIS OF COLORECTAL CANCER
by: SINEM KADIOGLU
Published: (2024)

BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients
by: Ang, P.W., et al.
Published: (2014)

Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: An Asian Experience
by: Lim, E.H., et al.
Published: (2016)

Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: An Asian Experience
by: Lim, E.H., et al.
Published: (2014)

Young colorectal cancer patients often present too late
by: Law J.-H., et al.
Published: (2018)

Impact of multidisciplinary tumour boards (MTB) on the clinicopathological characteristics and outcomes of resected colorectal liver metastases across time
by: Chen, L., et al.
Published: (2021)

Metallothionein as a Prognostic Biomarker in Breast Cancer
by: Bay, B.-H., et al.
Published: (2011)

IDENTIFYING AND OVERCOMING ISSUES OF SCREENING FOR COLORECTAL CANCER AMONGST FAMILY MEMBERS OF COLORECTAL CANCER PATIENTS
by: TAN KER KAN (CHEN KEGANG)
Published: (2019)

Identification of 42 genes linked to stage II colorectal cancer metastatic relapse
by: Al-Temaimi, R.A, et al.
Published: (2020)

KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma
by: Pang, N.K.B., et al.
Published: (2014)

CT appearance of Varicella Zoster lesions in liver and spleen in an immunocompetent patient
by: Venkatesh, S.K., et al.
Published: (2011)